Correction: Human anti-HIV IgM detection by the OraQuick ADVANCE® Rapid HIV 1/2 Antibody Test
OraSure Technologies Inc., Bethlehem, PA, USA
- Published
- Subject Areas
- Keywords
- Licence
- This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
- Cite this article
- 2018. Correction: Human anti-HIV IgM detection by the OraQuick ADVANCE® Rapid HIV 1/2 Antibody Test. PeerJ 6:e4430/correction-1 https://doi.org/10.7717/peerj.4430/correction-1
Corrigendum:
After publication, the authors noticed that the wrong version of Figure 3 was inadvertently published. We have replaced this figure with the correct version. In the correct figure, labels for HIV-1 Peptides, HIV-2 Peptides, and Biotinylated rAg have been removed from the blocker pad and legend.
The authors also noticed a typographical error in the third paragraph of the Discussion section. "... able to detect seroconversion an average of 1.5 days earlier than automated assays" has been amended to "... able to detect seroconversion an average of 1.5 days later than automated assays."